QA: G1 Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001560241_2019_G1_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001560241, G1 Therapeutics Inc

  xvar xval
0 AssetsCurrent 370,133,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,137,000
3 remainder_Assets 0
4 LiabilitiesCurrent 12,362,000
5 LiabilitiesNoncurrent 88,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,603,000
9 ResearchAndDevelopmentExpense 70,683,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,998,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 371,270,000
1 Liabilities 12,450,000
2 Expenses 89,286,000
3 Revenues 0
4 StockholdersEquity 358,820,000
5 NetIncome -85,288,000
6 ComprehensiveNetIncome -85,288,000
7 BaseVar 238,502,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.63
9 EconomicCapitalRatio 4.12

Edgar->Model Mapping

Feature Distribution

Change over Time